Beta-1,3/1,6-glucan · supplement
Evidence tier: moderate
A foundational innate immune trainer with strong evidence for cold prevention and immune resilience.
Two mechanisms, matching the two products. For OAT beta glucan and cholesterol, the mechanism is physical and well accepted: the soluble fibre forms a viscous gel in the gut, traps bile acids and reduces their reabsorption, forcing the liver to draw on circulating cholesterol to make more. Viscosity is the active property, which is why processing that degrades molecular weight destroys the effect and why the food form matters. For YEAST beta 1,3 or 1,6 glucan and immunity, the proposed mechanism is that the polysaccharide is recognised by the dectin 1 receptor on macrophages and neutrophils and primes the innate immune response, sometimes called trained immunity. That mechanism is real in the laboratory. Its translation into fewer or shorter colds in people is what the thin trial base has not convincingly shown.
Moderate overall, but ONLY because the label 'beta glucan' covers two different molecules from two different sources with two very different evidence grades, and the strong one is not the one the product is sold for. OAT AND BARLEY BETA GLUCAN, for cholesterol, is genuinely strong and this is where honesty cuts in the ingredient's favour. The European Food Safety Authority concluded that a CAUSE AND EFFECT relationship has been established between consumption of oat beta glucan and the lowering of blood LDL cholesterol, and authorised the claim under Article 14, based on a dossier of 3 meta analyses and 19 randomised controlled trials. The US FDA independently authorises a health claim, codified at 21 CFR 101.81, that 3 g or more per day of beta glucan soluble fibre from whole oats or barley is associated with reduced risk of coronary heart disease, and that claim meets the FDA's Significant Scientific Agreement standard, its highest evidentiary bar. Two major regulators, on two continents, independently. That is a real finding and it deserves to be stated as one. The dose that earns it is 3 g DAILY, which is a food level intake, not a capsule. YEAST BETA 1,3 or 1,6 GLUCAN, for immunity, which is the framing the seed leads with and the form sold in supplements, is much weaker. The 2021 systematic review and meta analysis in European Journal of Nutrition pooled 13 randomised trials and found yeast beta glucan reduced the incidence of upper respiratory tract infection (odds ratio 0.345, 95 percent CI 0.192 to 0.620), the number of episodes and their duration. But the authors' own caveat is the operative sentence: due to the HIGH HETEROGENEITY and the small number of included studies, more high quality research is warranted. The trials are small, several are tied to a single commercial ingredient brand, and there is no regulator anywhere that has accepted an immune claim for beta glucan. EFSA has in fact rejected immune function claims for beta glucans. So: strong for oat beta glucan at 3 g a day for LDL, weak for yeast beta glucan for colds.
For LDL cholesterol: 3 g daily of oat or barley beta glucan, which is the threshold both EFSA and the FDA specify, and the effect is dose dependent below it. For immune support: yeast beta glucan trials generally used 100 to 500 mg daily, most commonly 250 mg, but since the outcome itself is uncertain the dose is a description of practice rather than a recommendation.
250 to 500 mg daily during cold season or chronically; 3 g daily oat beta-glucan for cholesterol.
Very safe. Caution in solid organ transplant (theoretical immune activation).
Pregnancy: caution
Breastfeeding: caution
Active compounds: beta-1,3/1,6-glucan (yeast and fungal), beta-1,3/1,4-glucan (oat and barley)
Remedies using Beta Glucan · Browse by body system · Check it against what you take
*These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.